Executive Summary
Keynote
The Potential and Reality of Data Sharing in Fulfilling the FDA Vision of an Evidence-Generation System
Sean Khozin, MD, MPH, Associate Director (Acting), FDA Oncology Center of Excellence, and Founding director, Information Exchange and Data Transformation
Main Sessions
Unlocking Insights Through Open Science and Crowdsources Solutions
Project Data Sphere Initiative Update
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials
The Path Forward: Enabling Immuno-Oncology Research Innovation, Understanding Rare but Serious Immune-Related Adverse Events
Attendees
Alliance for Clinical Trials in Oncology
AstraZeneca
Celgene Corp.
Helsinn Therapeutics U.S., Inc.
Hogan Lovells US LLC
Kaggle, Inc.
National Cancer Institute, NIH
Novartis
NQ Oncology
Pancreatic Cancer Action Network
Parker Institute for Cancer Immunotherapy
Pfizer, Inc.
RTI
SAS
Tulane University School of Medicine
University of Colorado
Keynote
The Potential and Reality of Data Sharing in Fulfilling the FDA Vision of an Evidence-Generation System
Sean Khozin, MD, MPH, Associate Director (Acting), FDA Oncology Center of Excellence, and Founding director, Information Exchange and Data Transformation
Main Sessions
Unlocking Insights Through Open Science and Crowdsources Solutions
- James Costello, PhD, University of Colorado
- Addison Howard, Kaggle
- Gustavo Stolovitzky, PhD, IBM
Project Data Sphere Initiative Update
- Steven Cohen, Research Triangle Institute
- John Dornan, Project Data Sphere
- Dave Handelsman, Project Data Sphere
- Paul Kluetz, MD, FDA
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials
- Gideon Blumenthal, MD, FDA
The Path Forward: Enabling Immuno-Oncology Research Innovation, Understanding Rare but Serious Immune-Related Adverse Events
- Laleh Amiri-Kordestani, MD, FDA
Attendees
Alliance for Clinical Trials in Oncology
AstraZeneca
Celgene Corp.
Helsinn Therapeutics U.S., Inc.
Hogan Lovells US LLC
Kaggle, Inc.
National Cancer Institute, NIH
Novartis
NQ Oncology
Pancreatic Cancer Action Network
Parker Institute for Cancer Immunotherapy
Pfizer, Inc.
RTI
SAS
Tulane University School of Medicine
University of Colorado
